eMaps digital market access knowledge hub offers free month’s subscription to all UK content starting early November
Support for life science innovators in healthcare is available in the form of eMaps, a digital platform that guides SMEs and innovators through the complex path to market access. eMaps will help SMEs and innovators with regulatory approval, navigating reimbursement systems and adoption in key healthcare markets across the UK and the USA. Modules for other markets in Europe and beyond will follow soon. Innovators will have the opportunity to take advantage of a free promotional offer commencing early November which would include all of the UK content (Digital Health, MedTech and Biotech / Drugs) being available for free for a whole month with no obligation to buy. Subscription to this content is normally priced at £50 per module per month. All the user has to do is navigate to https://emaps.co/free-month/ and register with the promotional code (available from 4th November) which will instantly activate free access to the modules.
eMaps differentiates itself from the competition in providing engaging video and interactive content from subject matter experts on best practice to achieving the most cost-effective route to market. This includes testimony from established SMEs and innovators that share learnings from negative experiences and critical success factors from their own journeys. The rich array of content also supports SMEs in healthcare to understand key market access barriers and how they can mitigate and overcome these where possible.
Pathways to adoption
The platform provides complete pathway to adoption information for innovators navigating Digital Health, Med Tech and Diagnostics, and Drugs and Biotech markets.
eMaps delivers a training-based experience to help you understand market entry into healthcare and plan for the challenges ahead, achieving market readiness in the area of healthcare. It will save time, effort and cost in developing and implementing your company’s market access strategy.
eMaps has modules currently available for the UK and USA, but modules are being finalised for accessing healthcare markets across Europe such as Germany, France, Spain, Italy, Portugal, Sweden and Denmark.
Who developed eMaps
The eMaps platform was developed by the Oxford Academic Health Science Network(AHSN), an NHS organisation in England that provides support for SMEs in healthcare and life science innovators with clinical innovation adoption and market access in healthcare. A consortium of expert partners from key healthcare markets across Europe and the USA was formed by the Oxford AHSN to develop a digital healthcare knowledge hub. This platform was designed as a suite of online modules to support SMEs and innovators navigate the complexities around accessing healthcare markets.
Early feedback from users on the eMaps platform shows the positive impact it has already had on SMEs accessing healthcare markets in the UK and the market entry support it offers for innovators.
’I found the content to be invaluable in understanding market access barriers and envisage it will save a huge amount of time navigating the UK healthcare market structure and pathways to market access’
Research Scientist & Product Architect
Oxford University Innovation
“I found eMaps to be well structured and extremely useful in understanding the UK health market access systems and in particular the modules on pathways to reimbursement in healthcare and procurement, where it demystifies the market access process.”
Clinical research fellow and academic clinical lecturer in general surgery
Nufield Department of Population Health